Core Viewpoint - Metallus Inc. is under investigation for potential securities fraud and unlawful business practices, following a disappointing financial report that led to a significant drop in stock price [1][2]. Financial Performance - Metallus reported non-GAAP earnings per share of $0.07 for Q1 2025, which was $0.05 below consensus estimates [2]. - The company's stock price fell by $1.48, or 11.31%, closing at $11.61 per share on May 9, 2025, after the earnings announcement [2]. Company Background - Pomerantz LLP is a prominent law firm specializing in corporate, securities, and antitrust class litigation, with a history of fighting for victims of securities fraud and corporate misconduct [3].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Globus Medical, Inc. and its officers or directors [1] Financial Performance - On May 8, 2025, Globus reported Q1 2025 financial results, with non-GAAP earnings per share of $0.68, missing consensus estimates by $0.06 [2] - Revenue for the same period was $598.12 million, falling short of consensus estimates by $27.78 million and reflecting a 1.4% year-over-year decline [2] - The decline in performance was attributed to softer Enabling Technology deal closures, temporary supply chain disruptions related to integration, and the timing of international distributor orders [2] Market Reaction - Following the financial results announcement, Globus's stock price dropped by $16.64 per share, or 22.96%, closing at $55.82 per share on May 9, 2025 [2]

Core Viewpoint - A lawsuit has been filed against BigBear.ai Holdings, Inc. and its senior executives for potential violations of federal securities laws, specifically under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Company Overview - BigBear.ai is an AI-driven technology solutions company that focuses on operationalizing AI through data analysis, providing insights in national security, supply chain management, and digital identity and biometrics [3]. Financial Events - BigBear.ai went public through a SPAC transaction, merging with GigCapital4 Merger Sub Corporation and subsequently with GigCapital4, Inc. The company issued $200 million in unsecured convertible notes with a maturity date of December 15, 2026 [4]. - The company improperly accounted for the 2026 Convertible Notes, leading to misstatements in its financial statements [4]. Stock Performance - On March 18, 2025, BigBear.ai announced a delay in filing its 2024 10-K, stating that prior financial statements since fiscal year 2021 should not be relied upon, resulting in a stock price decline of approximately 15%, from $3.49 to $2.97 per share [5]. - Following the filing of the restated 2024 10-K on March 25, 2025, which revealed a material weakness in internal controls, the stock price fell about 9%, from $3.51 to $3.19 per share [6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Everus Construction Group, Inc. common stock during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who acquired Everus Construction common stock during the Class Period or through the spinoff from MDU Resources may be eligible for compensation without any out-of-pocket fees [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by June 3, 2025 [3]. - The lawsuit alleges that Everus Construction made false or misleading statements regarding its business operations, which led to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen has been recognized as a leading figure in the plaintiffs' bar, highlighting the firm's expertise in this area [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Solaris Energy Infrastructure, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on May 27, 2025 [1]. Group 1: Class Action Details - Investors who purchased Solaris Energy securities between July 9, 2024, and March 17, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The lead plaintiff must file a motion with the Court by May 27, 2025, to represent other class members in the litigation [3]. Group 2: Case Allegations - The lawsuit alleges that Solaris Energy made false and misleading statements regarding Mobile Energy Rentals LLC (MER), including its lack of corporate history in mobile turbine leasing and its non-diversified earnings stream [5]. - It is claimed that MER's co-owner has a criminal background associated with turbine-related fraud, which was not disclosed, leading to an overstatement of the commercial prospects from the MER acquisition [5]. - The lawsuit also asserts that Solaris Energy inflated profitability metrics by failing to properly depreciate its turbines, resulting in materially misleading statements about its business and operations [5].

NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BigBear.ai Holdings, Inc. (NYSE: BBAI) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in BigBear.ai, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/bigbearai-holdings-inc. Investors have until June 10, 2025, to ask the Court to be a ...

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving Fulgent Genetics, Inc. and its officers or directors [1]. Group 1: Investigation Details - The investigation is initiated on behalf of investors of Fulgent Genetics, Inc. [1]. - Investors are encouraged to contact Pomerantz LLP for more information regarding the investigation [1]. Group 2: Recent Developments - On February 28, 2025, Fulgent disclosed a civil investigative demand from the U.S. Department of Justice concerning potential false claims under the Uninsured Program [3]. - Following this disclosure, Fulgent's stock price decreased by $0.41 per share, representing a 2.61% decline, closing at $15.28 per share on March 3, 2025 [3].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Biohaven Ltd. and its officers or directors [1] Group 1: Company Developments - On May 14, 2025, Biohaven announced that the FDA extended the PDUFA date for its new drug application for the treatment of spinocerebellar ataxia by three months to allow for a full review of recent submissions [3] - Following the FDA announcement, Biohaven's stock price dropped by $3.84 per share, or 19.53%, closing at $15.82 per share on May 15, 2025 [3] Group 2: Legal Investigation - Pomerantz LLP is reaching out to investors of Biohaven to investigate claims related to potential securities fraud [1] - The firm is recognized for its expertise in corporate, securities, and antitrust class litigation, having a history of recovering multimillion-dollar damages for victims of securities fraud [4]

Core Viewpoint - The Gross Law Firm is notifying shareholders of Ibotta, Inc. regarding a class action lawsuit due to alleged misleading statements related to a contract with Kroger, which could have significant implications for investors [1][2]. Group 1: Allegations and Legal Context - The lawsuit alleges that Ibotta failed to disclose the at-will nature of its contract with Kroger, which allowed Kroger to terminate the agreement without notice, posing a risk to investors [2]. - Ibotta provided detailed information about its contract with Walmart but did not adequately warn investors about the potential risks associated with the Kroger contract [2]. Group 2: Shareholder Actions and Deadlines - Shareholders who purchased Ibotta shares during the specified class period are encouraged to register for the class action, with a deadline set for June 16, 2025 [3]. - Once registered, shareholders will receive updates on the case through a portfolio monitoring software, and there is no cost to participate [3]. Group 3: Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to misleading statements or omissions by companies [4]. - The firm emphasizes its commitment to responsible business practices and good corporate citizenship [4].

Core Viewpoint - A lawsuit has been filed against BigBear.ai Holdings, Inc. and certain senior executives for potential violations of federal securities laws, specifically under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Company Overview - BigBear.ai is an AI-driven technology solutions company that focuses on operationalizing AI through data analysis, providing insights in national security, supply chain management, and digital identity and biometrics [3]. Financial Events - BigBear.ai went public through a SPAC transaction, merging with GigCapital4 Merger Sub Corporation and subsequently with GigCapital4, Inc. The company issued $200 million in unsecured convertible notes with a maturity date of December 15, 2026 [4]. - The company improperly accounted for the 2026 Convertible Notes, leading to misstatements in several previously issued financial statements [4]. Stock Performance - On March 18, 2025, BigBear.ai delayed the filing of its 2024 10-K, stating that certain financial statements since fiscal year 2021 should no longer be relied upon, resulting in a stock price decline of approximately 15%, from $3.49 to $2.97 per share [5]. - Following the filing of the restated 2024 10-K on March 25, 2025, which disclosed a material weakness in internal control over financial reporting, the stock price fell about 9%, from $3.51 to $3.19 per share [6].